Neumann Diagnostics
Latest round
- Series A
Last raised
- Nov 2018
Total raised
- Undisclosed
Investors
- 1
About Neumann Diagnostics
Based in Hungary, Neumann Diagnostics Ltd. operates as a biotechnology company that focuses on the development of Confidence Assay, a molecular diagnostics technology that enables to detect human papillomavirus (HPV) infections.
Who invested in Neumann Diagnostics
1 investor across 1 round
See all investors in Neumann Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 1, 2018
Amount
Undisclosed
Investors
Questions about Neumann Diagnostics
Who invested in Neumann Diagnostics?
Neumann Diagnostics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neumann Diagnostics raised?
Neumann Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neumann Diagnostics last raise money?
Neumann Diagnostics's most recent round on record is a Series A, in Nov 2018.
What does Neumann Diagnostics do?
Based in Hungary, Neumann Diagnostics Ltd.
Where is Neumann Diagnostics headquartered?
Neumann Diagnostics is headquartered in Hungary.
Which VCs invest in companies like Neumann Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Neumann Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neumann Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.